Objective: Bladder cancer can be imaged as a sustaining multistage course accumulating genetic and epigenetic changes. Moreover, plenty of studies uncovered that A-to-I RNA editing is an essential part of the growth of normal cells and involved in the variety of biological pathways. To better understand bladder cancer pathogenesis at the molecular level and to uncover novel tumor-initiating events, we integrate RNA-Seq data derived from 15 bladder cancer/normal paired samples. Methods: A total of 15 bladder cancer/normal paired samples are obtained. We conduct transcriptome sequencing and on fifteen pairs of bladder cancer and matched adjacent tissues to identify RNA editing events. Results: Six tumor samples obtained are low-grade bladder cancer (superficial), nine high-grade bladder cancer (invasive). Statistical analyses reveal no significant alterations in the number of editing site between lowgrade samples and high-grade samples. Further analysis uncovers that three non-synonymous edits exist in normal samples, and one of them, SON is a normal specific edit. Total 35 non-synonymous edits are identified in all the tumor samples. Further, tumor specific edited gene ANIZ1 is detected in two of the high-grade tumor samples (B59 and B71), suggesting that ANIZ1 may contribute to the progression of urinary bladder cancer. Conclusions: In this study, 15 bladder cancer/normal paired samples are included to investigate the difference between normal and tumor samples using a revised RNA editing identification method. Multiple RNA editing events are discovered in tumor and normal samples that indicate RNA editing plays a significant role in bladder cancer. Our study is the first one to research RNA editing events at exon genome level in bladder as we are known and it may offer a comprehensive view of the role of RNA editing on bladder cancer.
Investigation of RNA editing in urinary bladder cancer by transcriptome sequencing analysis. Transl Androl Urol 2015;4(S1):AB163. doi: 10.3978/j.issn. 2223-4683.2015.s163 AB164. An epigenetic biomarker combination of EOMES, pcdh17, and pou4f2 detects bladder cancer accurately from methylation analyses of urine sediment DNA in Han Chinese Song Wu 1,2 , Yongqiang Wang 1,2 , Yuan Yu 1,2 Objective: To recognize a novel and optimized combination of epigenetic biomarkers capable of returning higher sensitivity and specificity synergistically in pathologically varied sample groups for urine sediment examination of bladder cancer (BlCa). Methods: Methylation levels of seven candidate biomarkers (EOMES, GDF15, NID2, PCDH17, POU4F2, TCF21, and ZNF154) in 58 urothelial cell carcinoma (UCC) patients, 20 infected urinary calculi (IUC) patients, 20 kidney cancer (KC) patients, and 30 healthy volunteers (HV) were quantified by qMSP using the sediment DNA of urine samples. Standard curves and receiver operating characteristic (ROC) curves were generated for each biomarker. The combining predictors of all the possible biomarker combinations were calculated through logistic regression model. Subsequently, the ROC curves of the three combinations that have yielded the best performing combining predictors were constructed.
Results: From the samples provided, the top three biomarker combinations (C) returned high sensitivity and specificity of 91.38% and 94.29% from PCDH17 + POU4F2 (C1), 91.38% and 90.00% from PCDH17 + POU4F2 + NID2 (C2), and 93.10% and 92.86% from PCDH17 + POU4F2 + EOMES (C3) consequently. These combinations provide greater sensitivities and specificities than any examined single biomarkers, except for C2, which has a lower specificity compare to POU4F2 (92.86%). Conclusions: Compound biomarker panels were shown to be capable of detecting BlCa effectively by utilizing urine sediment DNA. Due to the performance of higher sensitivity and specificity when compared to single biomarker examinations in BlCa patients and the diverse control groups, these panels are particularly suitable for mass-scale routine BlCa screening. AB165. The role of inflammatory cytokines and MAPK signaling in chronic prostatitis/chronic pelvic pain syndrome with related mental health disorders Objective: Mental health disorders (MHD) in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) have been widely studied. However, the underlying molecular mechanisms and, in particular, role of inflammatory cytokines and their associated signaling pathways has not been investigated in detail. To determine the potential role of cytokines and associated signaling pathways in CP/CPPS patients with MHD and in a CP/CPPS animal model. Methods: Between July 2012 and August 2013, 810 CP/ CPPS patients and 992 control subjects were enrolled in this case-control multicenter study, and serum cytokine levels were measured. Male Sprague-Dawley rats received multiple intracutaneous injections (neck, tail, and pelvic limbs) of an immuno-agent along with a pertussisdiphtheria-tetanus triple vaccine for autoimmune CP/ CPPS development. After 45 and 60 days behavioral analysis was performed, and prostate and specific brain areas related to MHD were subjected to RT-qPCR and Western blot analysis of cytokine signaling pathways. Moreover, histological prostate examination, and detection of IL-1β levels in serum and cerebrospinal fluid (CSF) was performed. Results: In CP/CPPS patients with significant MHD, elevated IL-1α, IL-1β, IL-4, IL-13, and TNF-α serum levels were observed. The above five cytokines in CP/ CPPS rats were significantly elevated in prostate tissue (P<0.05), and IL-1β levels were elevated in serum and CSF. In behavioral tests, CP/CPPS rats showed anxietyand depression-like symptoms, and impaired spatial and associative memory performance (P<0.05). In the CP/CPPS group ERK1/2 phosphorylation levels were increased in the amygdala and nucleus accumbens, and decreased in the hippocampus and caudate nucleus. Lack of human CSF data in present research may limit the translational values of the results. Conclusions: These data suggest that prostate-derived cytokines, especially IL-1β, cross the blood brain barrier and may lead to enhanced ERK1/2 signaling in several brain areas, possibly underlying induction of CP/CPPSrelated MHD.
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